Toggle navigation
Home
Journals
Journal Policies
Open Access Policy
Peer Review Policy
Plagiarism Policy
Copyright Policy
Licensing Policy
Human Rights Policy
APC Waiver Policy
Withdrawal Policy
Errata Retractions and Corrigenda Policy
Digital Preservation Policy
Advertising Policy
Conflict of Interest Policy
Data Sharing Policy
Informed Consent Policy
Publication Ethics and Publication Malpractice Statement
Guidelines
Open Access
Editor Guidelines
Editor Policies
Special Issues Guidelines
Reviewer Guidelines
DOI
Citation
AI and Plagiarism
Publication Process
Author
Author Guidelines
Membership
Processing Fee
Pay Online
Peer Review Process
Journal of Embryology & Stem Cell Research (JES)
Volume 4 Issue 2
Research Article
Creating the Next Generation Human 2n=44 from Embryonic Stem Cells
Dehghan FK* and Kamalidehghan B
DOI:
10.23880/jes-16000143
Full Text
PDF
Case Report
Unusual Termination of the Facial Vein into External Jugular Vein and its Clinical Implication
Lufukuja GJ* Lugwisha P Mwaipaja E and Byabato B
DOI:
10.23880/jes-16000144
Full Text
PDF
Mini Review
Alzheimer’s Disease and Stem Cell
El Shawarby A and Omar SMM*
DOI:
10.23880/jes-16000145
Full Text
PDF
Submit Manuscript
Track your Article
Indexed in
Member
Upcoming Articles
view all
Many Discrete Worlds
(PhIJ)
High-Accuracy CNN Architecture for Automated Detection of Tomato Leaf Diseases
(OAJAR)
The Genesis of Psychopathology
(PhIJ)
Emotional Intelligence in the Age of AI: An Educational Problem
(PPRIJ)
The Theory of Physical Spaces
(PhIJ)
llenges in Utilization of Maternal Health Services for Women and Young Females of Reproductive Age Living in Urban Slums in Megacities Jakarta, Lagos And Kinshasa
(IJCMC)
Neonatal Sepsis in Developing Countries: A Practical Clinical Review
(IJCMC)
Noentarion: Toward a New Ontological Category for Non-Biological Agency in the Postmodern Age
(PhIJ)
×
Tracking Details
About Us
Mission
Publication Process
Guidelines
Author
Editor
Reviewer
Open Access
Services
Journals
E-Books
Conferences
Connect With us
Facebook
Instagram
Twitter
Linkedin